Literature DB >> 20375710

Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk.

Emma L Northwood1, Faye Elliott, David Forman, Jennifer H Barrett, Murray J V Wilkie, Francis A Carey, Robert J C Steele, Roland Wolf, Timothy Bishop, Gillian Smith.   

Abstract

OBJECTIVES: We have earlier shown that diet and xenobiotic metabolizing enzyme genotypes influence colorectal cancer risk, and now investigate whether similar associations are seen in patients with premalignant colorectal adenomas (CRA), recruited during the pilot phase of the Scottish Bowel Screening Programme.
METHODS: Nineteen polymorphisms in 13 genes [cytochrome P450 (P450), glutathione S-transferase (GST), N-acetyl transferase, quinone reductase (NQ01) and microsomal epoxide hydrolase (EPHX1) genes] were genotyped using multiplex PCR or Taqman-based allelic discrimination assays and analyzed in conjunction with diet, assessed by food frequency questionnaire, in a case-control study [317 CRA cases (308 cases genotyped), 296 controls]. Findings significant at a nominal 5% level are reported.
RESULTS: CRA risk was inversely associated with fruit (P=0.02, test for trend) and vegetable (P=0.001, test for trend) consumption. P450 CYP2C9*3 heterozygotes had reduced CRA risk compared with homozygotes for the reference allele [odds ratio (OR): 0.60; 95% confidence interval (CI): 0.36-0.99], whereas CYP2D6*4 homozygotes (OR: 2.72; 95% CI: 1.18-6.27) and GSTM1 'null' individuals (OR: 1.43; 95% CI: 1.04-1.98) were at increased risk. The protective effect of fruit consumption was confined to GSTP1 (Ala114Val) reference allele homozygotes (OR: 0.49; 95% CI: 0.34-0.71, P=0.03 for interaction). CRA risk was not associated with meat consumption, although a significant interaction between red meat consumption and EPHX1 (His139Arg) genotype was noted (P=0.02 for interaction).
CONCLUSION: We report the novel associations between P450 genotype and CRA risk, and highlight the risk association with GSTM1 genotype, common to our CRA and cancer case-control series. In addition, we report a novel modifying influence of GSTP1 genotype on dietary chemoprevention. These novel findings require independent confirmation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375710     DOI: 10.1097/FPC.0b013e3283395c6a

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  19 in total

Review 1.  System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.

Authors:  Zhi-Qiang Zhao; Qing-Kai Guan; Fei-Yun Yang; Peng Zhao; Bing Zhou; Zhi-Jun Chen
Journal:  Tumour Biol       Date:  2011-12-13

2.  Polymorphisms in heterocyclic aromatic amines metabolism-related genes are associated with colorectal adenoma risk.

Authors:  Monika Eichholzer; Sabine Rohrmann; Aline Barbir; Silke Hermann; Birgit Teucher; Rudolf Kaaks; Jakob Linseisen
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

3.  Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.

Authors:  Rui Ding; Shilei Lin; Daojun Chen
Journal:  Int J Colorectal Dis       Date:  2012-01-04       Impact factor: 2.571

4.  Association between cytochrome P450 2C9 gene polymorphisms and colorectal cancer susceptibility: evidence from 16 case-control studies.

Authors:  Hong Wang; Li Ren; Yifeng He; Ye Wei; Zenggan Chen; Weige Yang; Yipeng Fu; Xiaoyue Xu; Weigao Fu; Guangfu Hu; Wenhui Lou
Journal:  Tumour Biol       Date:  2014-01-11

5.  CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis.

Authors:  Yong Xie; Guo-Qing Liu; Xiong-Ying Miao; Yi Liu; Wei Zhou; De-Wu Zhong
Journal:  Tumour Biol       Date:  2011-12-22

Review 6.  Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies.

Authors:  Stella Aslibekyan; Robert J Straka; Marguerite R Irvin; Steven A Claas; Donna K Arnett
Journal:  Expert Rev Cardiovasc Ther       Date:  2013-03

7.  CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.

Authors:  Elizabeth L Barry; Elizabeth M Poole; John A Baron; Karen W Makar; Leila A Mott; Robert S Sandler; Dennis J Ahnen; Robert S Bresalier; Gail E McKeown-Eyssen; Cornelia M Ulrich
Journal:  Cancer Causes Control       Date:  2012-10-19       Impact factor: 2.506

8.  Meta-analysis of cytochrome P-450 2C9 polymorphism and colorectal cancer risk.

Authors:  Shuo Liang; Jinsong Hu; Jingsong Hu; Weijun Cao; Sanjun Cai
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Quantitative assessment of the effect of cytochrome P450 2C9 gene polymorphism and colorectal cancer.

Authors:  Yuan Zhao; Yusong Han; Liang Zhang; Yichao Wang; Yushui Ma; Feng Zhang; Da Fu; Xiaofeng Wang
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  Analysis of the Functional Polymorphism in the Cytochrome P450 CYP2C8 Gene rs11572080 with Regard to Colorectal Cancer Risk.

Authors:  José M Ladero; José A G Agúndez; Carmen Martínez; Gemma Amo; Pedro Ayuso; Elena García-Martín
Journal:  Front Genet       Date:  2012-12-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.